These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 30191851)

  • 1. Will liquid biopsies improve outcomes for patients with small-cell lung cancer?
    Blackhall F; Frese KK; Simpson K; Kilgour E; Brady G; Dive C
    Lancet Oncol; 2018 Sep; 19(9):e470-e481. PubMed ID: 30191851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid Biopsy in Small Cell Lung Cancer-A Route to Improved Clinical Care?
    Church M; Carter L; Blackhall F
    Cells; 2020 Dec; 9(12):. PubMed ID: 33287165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small-Cell Lung Cancer: Is Liquid Biopsy a New Tool Able to Predict the Efficacy of Immunotherapy?
    Fasano R; Serratì S; Rafaschieri T; Longo V; Di Fonte R; Porcelli L; Azzariti A
    Biomolecules; 2024 Mar; 14(4):. PubMed ID: 38672414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Research Progress on the Application of Liquid Biopsy in the Diagnosis 
and Treatment of Small Cell Lung Cancer].
    Zhang X; Xu M; Li X; Su Y
    Zhongguo Fei Ai Za Zhi; 2022 Aug; 25(8):609-614. PubMed ID: 36002198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inferring the Evolution and Progression of Small-Cell Lung Cancer by Single-Cell Sequencing of Circulating Tumor Cells.
    Su Z; Wang Z; Ni X; Duan J; Gao Y; Zhuo M; Li R; Zhao J; Ma Q; Bai H; Chen H; Wang S; Chen X; An T; Wang Y; Tian Y; Yu J; Wang D; Xie XS; Bai F; Wang J
    Clin Cancer Res; 2019 Aug; 25(16):5049-5060. PubMed ID: 31113842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current and future applications of liquid biopsy in nonsmall cell lung cancer from early to advanced stages.
    Guibert N; Pradines A; Favre G; Mazieres J
    Eur Respir Rev; 2020 Mar; 29(155):. PubMed ID: 32051167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Tumor DNA Profiling in Small-Cell Lung Cancer Identifies Potentially Targetable Alterations.
    Devarakonda S; Sankararaman S; Herzog BH; Gold KA; Waqar SN; Ward JP; Raymond VM; Lanman RB; Chaudhuri AA; Owonikoko TK; Li BT; Poirier JT; Rudin CM; Govindan R; Morgensztern D
    Clin Cancer Res; 2019 Oct; 25(20):6119-6126. PubMed ID: 31300452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid Biopsy and Lung Cancer.
    Pisapia P; Malapelle U; Troncone G
    Acta Cytol; 2019; 63(6):489-496. PubMed ID: 30566947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer.
    Hodgkinson CL; Morrow CJ; Li Y; Metcalf RL; Rothwell DG; Trapani F; Polanski R; Burt DJ; Simpson KL; Morris K; Pepper SD; Nonaka D; Greystoke A; Kelly P; Bola B; Krebs MG; Antonello J; Ayub M; Faulkner S; Priest L; Carter L; Tate C; Miller CJ; Blackhall F; Brady G; Dive C
    Nat Med; 2014 Aug; 20(8):897-903. PubMed ID: 24880617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current and future perspectives of liquid biopsies in genomics-driven oncology.
    Heitzer E; Haque IS; Roberts CES; Speicher MR
    Nat Rev Genet; 2019 Feb; 20(2):71-88. PubMed ID: 30410101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single tube liquid biopsy for advanced non-small cell lung cancer.
    de Wit S; Rossi E; Weber S; Tamminga M; Manicone M; Swennenhuis JF; Groothuis-Oudshoorn CGM; Vidotto R; Facchinetti A; Zeune LL; Schuuring E; Zamarchi R; Hiltermann TJN; Speicher MR; Heitzer E; Terstappen LWMM; Groen HJM
    Int J Cancer; 2019 Jun; 144(12):3127-3137. PubMed ID: 30536653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of circulating tumor DNA using target next-generation sequencing in extensive-stage small-cell lung cancer.
    Zhang J; Zhou N; Deng H; Chen X; Chen Q; Wang Q; Sun L; Wen Y; Cao X; Luo Z; Zhang J; Zhu W; Guo L
    Lung Cancer; 2023 Apr; 178():11-19. PubMed ID: 36758321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood-based tumour mutational burden analysis in NSCLC.
    Das M
    Lancet Oncol; 2018 Sep; 19(9):e446. PubMed ID: 30122616
    [No Abstract]   [Full Text] [Related]  

  • 14. Profiling of Circulating Free DNA Using Targeted and Genome-wide Sequencing in Patients with SCLC.
    Mohan S; Foy V; Ayub M; Leong HS; Schofield P; Sahoo S; Descamps T; Kilerci B; Smith NK; Carter M; Priest L; Zhou C; Carr TH; Miller C; Faivre-Finn C; Blackhall F; Rothwell DG; Dive C; Brady G
    J Thorac Oncol; 2020 Feb; 15(2):216-230. PubMed ID: 31629061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasticity of circulating tumor cells in small cell lung cancer.
    Seo J; Kumar M; Mason J; Blackhall F; Matsumoto N; Dive C; Hicks J; Kuhn P; Shishido SN
    Sci Rep; 2023 Jul; 13(1):11775. PubMed ID: 37479829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancer.
    Nong J; Gong Y; Guan Y; Yi X; Yi Y; Chang L; Yang L; Lv J; Guo Z; Jia H; Chu Y; Liu T; Chen M; Byers L; Roarty E; Lam VK; Papadimitrakopoulou VA; Wistuba I; Heymach JV; Glisson B; Liao Z; Lee JJ; Futreal PA; Zhang S; Xia X; Zhang J; Wang J
    Nat Commun; 2018 Aug; 9(1):3114. PubMed ID: 30082701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ex vivo culture of cells derived from circulating tumour cell xenograft to support small cell lung cancer research and experimental therapeutics.
    Lallo A; Gulati S; Schenk MW; Khandelwal G; Berglund UW; Pateras IS; Chester CPE; Pham TM; Kalderen C; Frese KK; Gorgoulis VG; Miller C; Blackhall F; Helleday T; Dive C
    Br J Pharmacol; 2019 Feb; 176(3):436-450. PubMed ID: 30427531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of a novel microfluidic device for epitope-independent enrichment of circulating tumour cells in patients with small cell lung cancer.
    Chudziak J; Burt DJ; Mohan S; Rothwell DG; Mesquita B; Antonello J; Dalby S; Ayub M; Priest L; Carter L; Krebs MG; Blackhall F; Dive C; Brady G
    Analyst; 2016 Jan; 141(2):669-78. PubMed ID: 26605519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of circulating biomarkers of obatoclax-induced cell death in patients with small cell lung cancer.
    Dean EJ; Cummings J; Roulston A; Berger M; Ranson M; Blackhall F; Dive C
    Neoplasia; 2011 Apr; 13(4):339-47. PubMed ID: 21472138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Circulating Tumor DNA for the Early Detection of Small-cell Lung Cancer.
    Fernandez-Cuesta L; Perdomo S; Avogbe PH; Leblay N; Delhomme TM; Gaborieau V; Abedi-Ardekani B; Chanudet E; Olivier M; Zaridze D; Mukeria A; Vilensky M; Holcatova I; Polesel J; Simonato L; Canova C; Lagiou P; Brambilla C; Brambilla E; Byrnes G; Scelo G; Le Calvez-Kelm F; Foll M; McKay JD; Brennan P
    EBioMedicine; 2016 Aug; 10():117-23. PubMed ID: 27377626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.